Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis
Year: 2017
Type: article
Abstract: Importance: It is unclear whether female carriers of the apolipoprotein E (APOE) ε4 allele are at greater risk of developing Alzheimer disease (AD) than men, and the sex-dependent association of mild cognitive impairment (MCI) and APOE has not been established. Objective: To determine how sex and APOE genotype affect the risks for developing MCI and AD. Data Sources: Twenty-seven independent research studies in the Global Alzheimer's Association Interactive Network with data on nearly 58 000 participants. Study Selection: Non-Hispanic white individuals with clinical diagnostic and APOE genotype data. Data Extraction and Synthesis: Homogeneous data sets were pooled in case-control analyses, and logistic regression models were used to compute risks. Main Outcomes and Measures: Age-adjusted odds ratios (ORs) and 95% confidence intervals for developing MCI and AD were calculated for men and women across APOE genotypes. Results: Participants were men and women between ages 55 and 85 years. Across data sets most participants were white, and for many participants, racial/ethnic information was either not collected or not known. Men (OR, 3.09; 95% CI, 2.79-3.42) and women (OR, 3.31; CI, 3.03-3.61) with the APOE ε3/ε4 genotype from ages 55 to 85 years did not show a difference in AD risk; however, women had an increased risk compared with men between the ages of 65 and 75 years (women, OR, 4.37; 95% CI, 3.82-5.00; men, OR, 3.14; 95% CI, 2.68-3.67; P = .002). Men with APOE ε3/ε4 had an increased risk of AD compared with men with APOE ε3/ε3. The APOE ε2/ε3 genotype conferred a protective effect on women (OR, 0.51; 95% CI, 0.43-0.61) decreasing their risk of AD more (P value = .01) than men (OR, 0.71; 95% CI, 0.60-0.85). There was no difference between men with APOE ε3/ε4 (OR, 1.55; 95% CI, 1.36-1.76) and women (OR, 1.60; 95% CI, 1.43-1.81) in their risk of developing MCI between the ages of 55 and 85 years, but women had an increased risk between 55 and 70 years (women, OR, 1.43; 95% CI, 1.19-1.73; men, OR, 1.07; 95% CI, 0.87-1.30; P = .05). There were no significant differences between men and women in their risks for converting from MCI to AD between the ages of 55 and 85 years. Individuals with APOE ε4/ε4 showed increased risks vs individuals with ε3/ε4, but no significant differences between men and women with ε4/ε4 were seen. Conclusions and Relevance: Contrary to long-standing views, men and women with the APOE ε3/ε4 genotype have nearly the same odds of developing AD from age 55 to 85 years, but women have an increased risk at younger ages.
Source: JAMA Neurology
Authors: Scott C. Neu, Judy Pa, Walter Kukull, Duane Beekly, Amanda Kuzma, Prabhakaran Gangadharan, Li-San Wang, Klaus Romero, Stephen P. Arneric, Alberto Redolfi, Daniele Orlandi, Giovanni B. Frisoni, Rhoda Au, Sherral Devine, Sanford Auerbach, Ana Espinosa, Mercè Boada, Agustín Ruiz, Sterling C. Johnson, Rebecca Koscik, Jiun-Jie Wang, Wen-Chuin Hsu, Yao-Liang Chen, Arthur W. Toga
Institutions: University of Southern California, University of Washington, National Alzheimer's Coordinating Center, University of Pennsylvania, Critical Path Institute, Centro San Giovanni di Dio Fatebenefratelli, University of Geneva, University Hospital of Geneva, Boston University, Framingham Heart Study, Fundació ACE, University of Wisconsin–Madison, Chang Gung University, Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital, Taoyuan Chang Gung Memorial Hospital, Keelung Chang Gung Memorial Hospital
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: National Institutes of Health, U.S. Food and Drug Administration, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering, National Center for Advancing Translational Sciences
Awards: UC Davis Alzheimer's Disease Core Center, Indiana Alzheimer Disease Center, G1747133292, University of Kentucky Alzheimer's Disease Core Center, Neurobiology of Alzheimer's Disease and Aging, Big Data for Discovery Science, Alzheimer's Disease Research Center, Southern California Clinical and Translational Science Institute, National Alzheimer's Coordinating Center, UCSD Alzheimer's Disease Research Center P50, Alzheimer's Disease Research Center, UCLA Alzheimer's Disease Research Center, Alzheimer's Disease Core Center, The Alzheimer's Disease Research Center at the University of California, Irvine, Wisconsin Registry for Alzheimer's Prevention, Stanford Alzheimer's Disease Research Center, Oregon Alzheimer's Disease Center, Rush Alzheimer's Disease Core Center, G5164707915, MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults, Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Core Center, Alzheimer's Disease Research Center - Overall, MRI, Genetics & Cognitive Precursors of AD and Dementia, The Framingham Heart Study, Wisconsin Alzheimer's Disease Research Center, University of Kansas Alzheimer's Disease Core Centers, Alzheimer's Disease Research Center, Alzheimer Disease Research Center, Yale Alzheimer Disease Research Center, Arizona Alzheimer's Disease Core Center, Johns Hopkins Alzheimer's Disease Research Center, Healthy Aging and Senile Dementia, Gender and APOE4 Effects on Brain Morphometry, Cognition, and Clinical Progression to Alzheimer's Disease., Boston University Alzheimer's Disease Center, Alzheimer's Disease Research Center, Massachusetts Alzheimer's Disease Research Center, Alzheimer's Disease Core Center, Emory Alzheimer's Disease Center, University of Florida - Mt. Sinai Medical Center AD Research Center, Laboratory of Neuro Imaging Resource (LONIR), Epidemiology of Dementia in the Framingham Study, Wisconsin Registry for Alzheimer's Prevention, THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE, Alzheimer's Disease Neuroimaging Initiative (ADNI4), Southern California Clinical and Translational Science Institute, Precursors of Stroke Incidence and Prognosis, Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study, New Approaches to Dementia Heterogeneity, Mayo Alzheimer's Disease Research Center
OpenAlex ID: W2745657465
